Analytical results from the RAINBOW study provided a regimen of ramucirumab and paclitaxel for patients with gastric/gastroesophageal adenocarcinoma. This is considered a new advancement in the treatment of advanced gastric/gastro-oesophageal cancer.

Vinmec Times City is one of the first medical facilities in Vietnam to offer the treatment regimen Ramucirumab combined with Paclitaxel for patients with gastric adenocarcinoma/esophagogastric junction. Initial results give good response, few side effects, suitable for elderly patients, poor health, have failed with other chemotherapy regimens.